Peer Specialist Chronicles His Epic Faith Journey and Experiences With Bipolar Disorder in Uplifting Collection of Poetry and Prose MILWAUKEE, July 20, 2020 (GLOBE NEWSWIRE) -- Making sense of a world that often makes no sense at all is one of life’s greatest challenges. In his book “55 Reflections of a Searching Skeptic:...

Author Reflects on Inspiring Journey of Spiritual Growth, Shares Experiences Healing from Bipolar Disorder in Debut Memoir NAPLES, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Author Bárbaro Baez Alvarez has published his debut, inspirational self-help memoir that twines his journey of spiritual growth with his experiences...

OWP Pharmaceuticals Announces Pre-IND Acknowledgement and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder NAPERVILLE, Ill., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...

OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder NAPERVILLE, Ill., Dec. 03, 2019 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...

Neuroleptics Market To Reach USD 15.41 Billion By 2026 | Reports And Data Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future. Market...